Supplemental Table 3. The mean level and change value from baseline of laboratory data and blood pressure at different time points in the GBM-IPTW cohort.
| HbA1C, % | LDL, mg/dL | SBP, mmHg | DBP, mmHg | |||||||||
| Fixed 5/10 | Fixed 5/20 | Free 5/10 | Fixed 5/10 | Fixed 5/20 | Free 5/10 | Fixed 5/10 | Fixed 5/20 | Free 5/10 | Fixed 5/10 | Fixed 5/20 | Free 5/10 | |
| Time point | ||||||||||||
| Baseline | 6.74 | 6.72 | 6.62 | 116.5 | 121.9 | 116.9 | 145.6 | 147.1 | 144.1 | 82.2 | 82.7 | 81.0 |
| 6 months | 6.86 | 6.87 | 6.75 | 93.0 | 85.8 | 97.5 | 140.0 | 139.3 | 140.6 | 78.7 | 78.2 | 78.6 |
| 12 months | 6.85 | 6.85 | 6.74 | 95.1 | 84.0 | 100.0 | 141.7 | 140.1 | 139.4 | 79.9 | 79.1 | 79.1 |
| 18 months | 6.76 | 6.84 | 6.60 | 91.7 | 87.3 | 97.4 | 141.4 | 137.3 | 139.1 | 79.2 | 76.4 | 77.6 |
| 24 months | 6.68 | 6.70 | 6.61 | 93.3 | 88.1 | 99.2 | 142.7 | 139.2 | 138.8 | 79.5 | 77.2 | 77.2 |
| 30 months | 6.63 | 6.85 | 6.69 | 92.9 | 86.3 | 106.7 | 141.1 | 137.6 | 140.8 | 77.5 | 77.1 | 79.5 |
| Change value | ||||||||||||
| 6 months | 0.12 | 0.15 | 0.13 | -23.5 | -36.1 | -19.5 | -5.6 | -7.7 | -3.5 | -3.4 | -4.5 | -2.4 |
| 12 months | 0.11 | 0.13 | 0.13 | -21.4 | -38.0 | -17.0 | -3.9 | -6.9 | -4.7 | -2.2 | -3.6 | -1.9 |
| 18 months | 0.02 | 0.12 | -0.02 | -24.8 | -34.6 | -19.5 | -4.2 | -9.7 | -5.0 | -2.9 | -6.3 | -3.4 |
| 24 months | -0.06 | -0.02 | -0.01 | -23.2 | -33.9 | -17.8 | -2.9 | -7.9 | -5.3 | -2.7 | -5.5 | -3.8 |
| 30 months | -0.11 | 0.13 | 0.07 | -23.6 | -35.7 | -10.3 | -4.5 | -9.5 | -3.3 | -4.7 | -5.6 | -1.4 |
DBP, diastolic blood pressure; GBM-IPTW, generalized boosted modeling-inverse probability of treatment weighting; HbA1C, glycated hemoglobin; LDL, low density lipoprotein cholesterol; SBP, systolic blood pressure.